Crinetics Pharmaceuticals Inc (CRNX)
57.08
+1.01
(+1.80%)
USD |
NASDAQ |
Nov 21, 15:50
Crinetics Pharmaceuticals Price to Book Value: 6.355 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 6.242 |
| November 19, 2024 | 6.142 |
| November 18, 2024 | 5.978 |
| November 15, 2024 | 6.092 |
| November 14, 2024 | 6.642 |
| November 13, 2024 | 6.560 |
| November 12, 2024 | 6.544 |
| November 11, 2024 | 6.681 |
| November 08, 2024 | 6.757 |
| November 07, 2024 | 6.630 |
| November 06, 2024 | 6.558 |
| November 05, 2024 | 6.409 |
| November 04, 2024 | 6.299 |
| November 01, 2024 | 6.284 |
| October 31, 2024 | 6.204 |
| October 30, 2024 | 6.181 |
| October 29, 2024 | 6.237 |
| October 28, 2024 | 6.335 |
| October 25, 2024 | 6.425 |
| October 24, 2024 | 6.512 |
| October 23, 2024 | 6.474 |
| October 22, 2024 | 6.608 |
| October 21, 2024 | 6.507 |
| October 18, 2024 | 6.550 |
| October 17, 2024 | 6.532 |
| Date | Value |
|---|---|
| October 16, 2024 | 6.525 |
| October 15, 2024 | 6.385 |
| October 14, 2024 | 5.886 |
| October 11, 2024 | 5.891 |
| October 10, 2024 | 5.740 |
| October 09, 2024 | 4.920 |
| October 08, 2024 | 5.018 |
| October 07, 2024 | 5.023 |
| October 04, 2024 | 5.157 |
| October 03, 2024 | 5.121 |
| October 02, 2024 | 5.243 |
| October 01, 2024 | 5.039 |
| September 30, 2024 | 4.959 |
| September 27, 2024 | 4.889 |
| September 26, 2024 | 4.873 |
| September 25, 2024 | 4.860 |
| September 24, 2024 | 4.800 |
| September 23, 2024 | 4.858 |
| September 20, 2024 | 5.120 |
| September 19, 2024 | 5.191 |
| September 18, 2024 | 5.084 |
| September 17, 2024 | 5.105 |
| September 16, 2024 | 5.197 |
| September 13, 2024 | 5.183 |
| September 12, 2024 | 4.936 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.124
Minimum
Oct 30 2020
7.739
Maximum
Sep 29 2023
3.909
Average
3.734
Median
Apr 21 2022
Price to Book Value Benchmarks
| Clearside Biomedical Inc | -- |
| Biomea Fusion Inc | 3.048 |
| NovaBay Pharmaceuticals Inc | 3.121 |
| Palatin Technologies Inc | -- |
| iBio Inc | 1.257 |
Price to Book Value Related Metrics
| PEG Ratio | -1.392 |
| Price | 57.08 |
| Earnings Yield | -6.53% |
| Market Cap | 5.293B |
| PEGY Ratio | -1.392 |